Psychometric evaluation and medication usage pattern in Covid-19 patients: A retrospective study
Authors: Surendhar Amargeeth  , Vedha Pal Jeyamani  , Santha Kumar V  , Reethika M  , Karthickeyan Krishnan  
Published: February 2024

Aim and objective: Assessing and evaluating Psychometric and medication usage patterns in COVID-19 patients retrospective study. assessing the post-COVID-19 subjects, evaluating the drug report in a post-COVID-19 subject, and measuring psychological status. Evaluation of the serious adverse reaction on the south-Indian population of the post-COVID-19 subject. Methodology: In which 150 subjects were taken and 127 participated. Inclusion criteria COVID-19 subject with adult age group, Patient was admitted and discharged before 3 months and above for COVID-19 with positive RT-PCR Report exclusion criteria patient who is recently tested for COVID-19 and pregnant women and lactating women and who are below the adult age group. Where follow-up is done to assess the psychometric evaluation it is a retrospective study with follow-up. Result: 127 patients were analyzed, in that there are 49 female subjects and 78 male subjects, therefore a total of 1 of 27 patients. The vaccination status of the subjects was analyzed with the data depleted. In that, 118 subjects were affected by Covid-19 before vaccination and only 9 subjects were affected after vaccination. In this pandemic, many subjects were Mentally stressed by their Neighborhood and 32 subjects were not stressed. The generalized anxiety disorder score shows that 15 subjects were currently experiencing low risk, 58 subjects were in the mild range, 32 subjects were in the moderate range and 22 subjects were in the mild range. The discharge medication data shows Vitamin C and Multivitamin tablets were prescribed nearly for 114-116 subjects, secondly, Pantoprazole was prescribed for 96 subjects, thirdly Prednisolone was prescribed for 96 subjects and Paracetamol was prescribed for 68 subjects. At last, other drugs are prescribed according to the Co-Morbidities of the subject. Conclusion: 127 patients were analyzed, in that there are 49 female subjects and 78 male subjects. 85 subjects were affected between ages 18-60 years whereas 42 subjects were affected above the age of 60 years. The vaccination and the non-vaccination status report shows that non-vaccinated people are affected more than vaccinated people. The Generalized Anxiety Disorder (GAD) category depletes that the patients experienced mild to moderate levels of anxiety. The Pearson Chi-square value is 23.271 and the P value is <0.001. This shows the association between anxiety with COVID-19 patients. The Major Depression Inventory (MDI) score depletes severe depression which might be due to the pandemic situation, economic situation, and local restrictions. The Pearson Chi-square value is 70.572 and the P-value is <0.001 showing that there is an association between depression and COVID in patients. This shows that post-COVID-19 affected subjects are experiencing Psychological effects in many terms. These Psychological effects are due to COVID-19 and the intake of Steroids during the treatment and after discharge.